EMEA-000120-PIP01-07-M05

Key facts

Invented name
Tygacil
Active substance
Tigecycline
Therapeutic area
Other
Decision number
P/0292/2014
PIP number
EMEA-000120-PIP01-07-M05
Pharmaceutical form(s)
Powder for solution for infusion
Condition(s) / indication(s)
  • Treatment of complicated intra-abdominal infections
  • Treatment of complicated skin and soft-tissue infections
Route(s) of administration
Intravenous use
Contact for public enquiries
Pfizer Limited

E-mail: pip_enquiries@pfizer.com
Tel. +44 (0)1304 646607

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000120-PIP01-07-M05
Compliance opinion date
12/12/2014
Compliance outcome
positive

Decision

How useful was this page?

Add your rating